Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma

doi:10.4254/wjh.v14.i9.1790

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3470)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-13) series, Tables (1-1) series.

Item

Count

PDF

151

WORD

HTML

1306

Figures (1-13)

308

Tables (1-1)

346

Sum=2163

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

310

Download

997

Sum=1307

Sep 27, 2022 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Sep 27, 2022; 14(9): 1790-1803
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1790

Full Size Figure Download Figure

Figure 6 Comparison of changes in T2-weighted and diffusion-weighted imaging findings and apparent diffusion coefficient values over time. ADC: Apparent diffusion coefficient; DWI: Diffusion-weighted imaging; T2W: T2-weighted; SBRT: Stereotactic body radiation therapy.

Citation: Serafini A, Ruggeri V, Inchingolo R, Gatti M, Guarneri A, Maino C, Ippolito D, Grazioli L, Ricardi U, Faletti R. Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma. World J Hepatol 2022; 14(9): 1790-1803
URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1790.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1790